Hemply Balance Holding

0.02 SEK

0.00%

Less than 1K followers

HMPLY

NGM Growth Market

Biotechnology & Pharmaceuticals

Health Care

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hemply Balance Holding

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Revenue0.11.20.30.10.20.30.80.2
EBITDA-1.2-0.6-0.1-0.2-0.2-0.0-0.5-0.1
EBIT-0.0-0.6-0.1-0.2-0.2-0.0-0.5-0.1
EBIT-%-27.3 %-53.4 %-36.0 %-250.0 %-109.1 %-0.9 %-56.4 %-29.6 %
Profit before taxes-0.0-0.6-0.1-0.2-0.2-0.0-0.5-0.1
Net income-0.0-0.6-0.1-0.2-0.2-0.0-0.5-0.1